These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29122967)

  • 21. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.
    Sakr HF; Abbas AM; Haidara MA
    J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):61-71. PubMed ID: 29161233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress.
    Quinn C; Rico MC; Merali C; Merali S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
    Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
    Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabonomics Application on Screening Serum Biomarkers of Golden Hamsters with Nonalcoholic Steatohepatitis Induced by High-Fat Diet.
    Hu J; Shen Y; Chen Y
    Comb Chem High Throughput Screen; 2023; 26(13):2280-2292. PubMed ID: 36815651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats.
    Zhao B; Zhang J; Zhao K; Zhao W; Shi Y; Liu J; Zeng L; Wang C; Zeng X; Shi J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4299-4307. PubMed ID: 38091076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary Long-Chain Fatty Acids Accelerate Metabolic Dysfunction in Guinea Pigs with Non-Alcoholic Steatohepatitis.
    Pedersen K; Ipsen DH; Skat-Rørdam J; Lykkesfeldt J; Tveden-Nyborg P
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CLINICAL EFFICACY OF S-ADENOSYLMETHIONINE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND CHRONIC KIDNEY DISEASE I-II STAGE.
    Antoniv A; Antofiychuk N; Danylyshina T; Trefanenko I; Shuper V
    Georgian Med News; 2017 Dec; (273):31-36. PubMed ID: 29328026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
    Jiang W; Liu J; Dai Y; Zhou N; Ji C; Li X
    J Gastroenterol Hepatol; 2015 May; 30(5):933-43. PubMed ID: 25559563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance.
    Wang T; Chen K; Yao W; Zheng R; He Q; Xia J; Li J; Shao Y; Zhang L; Huang L; Qin L; Xu M; Zhang Z; Pan D; Li Z; Huang F
    J Hepatol; 2021 May; 74(5):1038-1052. PubMed ID: 33248168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
    Nakahara T; Hyogo H; Ono A; Nagaoki Y; Kawaoka T; Miki D; Tsuge M; Hiraga N; Hayes CN; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Abe-Chayama H; Furusho H; Shintani T; Kurihara H; Miyauchi M; Takata T; Arihiro K; Chayama K
    J Gastroenterol; 2018 Feb; 53(2):269-280. PubMed ID: 28741270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β
    Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
    J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
    Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM
    Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.